RMFEX | SMVLX | RMFEX / SMVLX | |
Total Expense Ratio | 0.62 | 1.22 | 51% |
Annual Report Gross Expense Ratio | 0.62 | 1.22 | 51% |
Fund Existence | 23 years | 18 years | - |
Gain YTD | 14.641 | 3.590 | 408% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 3000 | 8% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 113B | 4.45B | 2,538% |
Annual Yield % from dividends | 1.46 | 1.04 | 141% |
Returns for 1 year | 6.97 | -3.03 | -230% |
Returns for 3 years | 45.05 | 37.24 | 121% |
Returns for 5 years | 60.50 | 81.63 | 74% |
Returns for 10 years | 100.86 | 118.23 | 85% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CFSIX | 22.22 | N/A | N/A |
Touchstone Sands Capital Select Growth Y | |||
GREAX | 11.08 | N/A | N/A |
Goldman Sachs Real Estate Securities A | |||
SSCGX | 37.79 | N/A | N/A |
SEI Small Cap Growth F (SIMT) | |||
FTDZX | 163.81 | N/A | N/A |
Franklin Biotechnology Discovery Adv | |||
TRTZX | 33.47 | -0.30 | -0.89% |
T. Rowe Price Mid-Cap Value Z |